Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Journal Articles:

- 417 records -

Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model

Gallardo-Rincón H, Saucedo-Martínez R, Mujica-Rosales R, Lee EM, Israel A, Torres-Beltran B, Quijano-González Ú, Atkinson ER, Kuri-Morales P, Tapia-Conyer R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:443-455

Published Date: 16 October 2017

Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy

Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:393-402

Published Date: 20 September 2017

Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points

Braz MAD, Vieira JN, Gomes FO, Silva PR, Santos OTM, Rocha IMGD, Sousa IMD, Fayh APT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:385-391

Published Date: 12 September 2017

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:375-383

Published Date: 13 September 2017

Novel biomarkers for prediabetes, diabetes, and associated complications

Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:345-361

Published Date: 14 August 2017

Personalized multistep cognitive behavioral therapy for obesity

Dalle Grave R, Sartirana M, El Ghoch M, Calugi S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:195-206

Published Date: 1 June 2017

Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study

Mendivil CO, Toloza FJK, Ricardo-Silgado ML, Morales-Álvarez MC, Mantilla-Rivas JO, Pinzón-Cortés JA, Lemus HN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:179-185

Published Date: 8 May 2017

Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis

Suksomboon N, Poolsup N, Darli Ko Ko H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:169-177

Published Date: 2 May 2017

Different consecutive training protocols to design an intervention program for overweight youth: a controlled study

Fiorilli G, Iuliano E, Aquino G, Campanella E, Tsopani D, Di Costanzo A, Calcagno G, di Cagno A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:37-45

Published Date: 16 January 2017

Coaching and barriers to weight loss: an integrative review

Muñoz Obino KF, Aguiar Pereira C, Caron-Lienert RS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:1-11

Published Date: 23 December 2016

rDNA insulin glargine U300 – a critical appraisal

Wang F, Zassman S, Goldberg PA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:425-441

Published Date: 2 December 2016

eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management

Rollo ME, Aguiar EJ, Williams RL, Wynne K, Kriss M, Callister R, Collins CE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:381-390

Published Date: 4 November 2016

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:371-380

Published Date: 1 November 2016

Myocutaneous revascularization following graded ischemia in lean and obese mice

Clark RM, Coffman B, McGuire PG, Howdieshell TR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:325-336

Published Date: 30 September 2016

Exercise portrayal in children’s television programs: analysis of the UK and Irish programming

Scully P, Reid O, Macken AP, Healy M, Saunders J, Leddin D, Cullen W, Dunne CP, O’Gorman CS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:317-324

Published Date: 23 September 2016

Role of sleep quality in the metabolic syndrome

Koren D, Dumin M, Gozal D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:281-310

Published Date: 25 August 2016

Teneligliptin in management of type 2 diabetes mellitus

Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:251-260

Published Date: 16 August 2016

Incremental increases in economic burden parallels cardiometabolic risk factors in the US

McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:233-241

Published Date: 2 August 2016

The relationship between the presence of lower urinary tract symptoms and waist circumference

Oliveira MC, Varella LR, Angelo PH, Micussi MT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:207-211

Published Date: 11 July 2016

Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque

Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:185-199

Published Date: 22 June 2016

Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome

Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:177-184

Published Date: 1 June 2016

Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia

Birhanu AM, Alemu FM, Ashenafie TD, Balcha SA, Dachew BA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:155-162

Published Date: 11 May 2016

Metabolic syndrome and C-reactive protein in bank employees

Cattafesta M, Bissoli NS, Salaroli LB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:137-144

Published Date: 10 May 2016

Childhood obesity: prevention is better than cure

Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:83-89

Published Date: 15 March 2016

Genistein treatment increases bone mass in obese, hyperglycemic mice

Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:63-70

Published Date: 15 March 2016

Long-term weight loss maintenance for obesity: a multidisciplinary approach

Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:37-46

Published Date: 26 February 2016

Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:535-542

Published Date: 30 October 2015

Bariatric surgery outcomes: a single-center study in the United Arab Emirates

Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:461-471

Published Date: 18 September 2015

Causes and consequences of obesity: epigenetics or hypokinesis?

Graham MR, Baker JS, Davies B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:455-460

Published Date: 16 September 2015

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:437-445

Published Date: 15 September 2015

Evaluation of the relationship between the pelvic floor muscles and insulin resistance

Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:409-413

Published Date: 28 August 2015

Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice

Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:399-407

Published Date: 26 August 2015

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Gurung T, Shyangdan DS, O’Hare JP, Waugh N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:363-386

Published Date: 10 August 2015

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice

Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:347-355

Published Date: 4 August 2015

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus

Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:339-345

Published Date: 27 July 2015

Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:219-226

Published Date: 29 April 2015

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:137-145

Published Date: 2 March 2015

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:121-127

Published Date: 26 February 2015

Effect of different exercise intensities on the pancreas of animals with metabolic syndrome

Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:115-120

Published Date: 13 February 2015

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation

Tojo A, Hatakeyama S, Kinugasa S, Nangaku M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:103-113

Published Date: 13 February 2015

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus

Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:97-101

Published Date: 11 February 2015

Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:57-63

Published Date: 23 January 2015

Type 2 diabetes in Brazil: epidemiology and management

Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:17-28

Published Date: 5 January 2015

Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children

Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:9-15

Published Date: 17 December 2014

Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics

Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:1-8

Published Date: 16 December 2014

Mechanism linking diabetes mellitus and obesity

Al-Goblan AS, Al-Alfi MA, Khan MZ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:587-591

Published Date: 4 December 2014

Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Mene-Afejuku TO, Adeyeye VO, Bamikole OJ, Bisiriyu LA, Ajayi OE, Ogunyemi SA, Oketona OA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:565-570

Published Date: 26 November 2014

Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep

Duckett SK, Volpi-Lagreca G, Alende M, Long NM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:553-563

Published Date: 20 November 2014

Integrated bariatric surgery residency

Eltorai AE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:543-544

Published Date: 13 November 2014

Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals

Wang X, DuBois DC, Sukumaran S, Ayyar V, Jusko WJ, Almon RR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:531-541

Published Date: 11 November 2014

Independent and combined effect of diet and exercise in adults with prediabetes

Sénéchal M, Slaght J, Bharti N, Bouchard DR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:521-529

Published Date: 31 October 2014

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations

Babakr AT, Elsheikh OM, Almarzouki AA, Assiri AM, Abdalla BE, Zaki HY, Fatani SH, NourEldin EM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:513-520

Published Date: 24 October 2014

Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents

Boodai SA, Cherry LM, Sattar NA, Reilly JJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:505-511

Published Date: 24 October 2014

Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience

Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:487-494

Published Date: 20 October 2014

Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications

Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:481-486

Published Date: 20 October 2014

The effect of a lifestyle intervention on metabolic health in young women

Dunn SL, Siu W, Freund J, Boutcher SH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:437-444

Published Date: 19 September 2014

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

Hernández-Ojeda J, Román-Pintos LM, Rodríguez-Carrízalez AD, Troyo-Sanromán R, Cardona-Muñoz EG, Alatorre-Carranza MP, Miranda-Díaz AG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:401-407

Published Date: 4 September 2014

Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment

Wang X, DuBois DC, Cao Y, Jusko WJ, Almon RR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:381-389

Published Date: 1 August 2014

Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco

El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:341-346

Published Date: 31 July 2014

Linking obesity with type 2 diabetes: the role of T-bet

Wali JA, Thomas HE, Sutherland APR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:331-340

Published Date: 22 July 2014

Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice

Leung L, Kang J, Rayyan E, Bhakta A, Barrett B, Larsen D, Jelinek R, Willey J, Cochran S, Broderick TL, Al-Nakkash L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:321-330

Published Date: 21 July 2014

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin

Ohira M, Yamaguchi T, Saiki A, Ban N, Kawana H, Nagumo A, Murano T, Shirai K, Tatsuno I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:313-319

Published Date: 17 July 2014

The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects

Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:305-312

Published Date: 11 July 2014

Relationship between insulin resistance and plasma vitamin D in adults

Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:297-303

Published Date: 7 July 2014

Abdominal obesity: causal factor or simply a symptom of obesity-related health risk

Oh S, Tanaka K, Noh JW, So R, Tsujimoto T, Sasai H, Kim M, Shoda J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:289-296

Published Date: 3 July 2014

Management of adult diabetic ketoacidosis

Gosmanov AR, Gosmanova EO, Dillard-Cannon E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:255-264

Published Date: 30 June 2014

AMPK activation: a therapeutic target for type 2 diabetes?

Coughlan KA, Valentine RJ, Ruderman NB, Saha AK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:241-253

Published Date: 24 June 2014

Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges

Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:211-223

Published Date: 23 June 2014

Metabolic profiling of plasma amino acids shows that histidine increases following the consumption of pork

Samman S, Crossett B, Somers M, Bell KJ, Lai NT, Sullivan DR, Petocz P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:203-210

Published Date: 19 June 2014

Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance

Maekawa S, Kawahara T, Nomura R, Murase T, Ann Y, Oeholm M, Harada M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:195-201

Published Date: 13 June 2014

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose

Das SS, Hayashi H, Sato T, Yamada R, Hiratsuka M, Hirasawa N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:185-194

Published Date: 24 May 2014

Prevalence and pattern of overweight and obesity in three rural communities in southwest Nigeria

Adebayo RA, Balogun MO, Adedoyin RA, Obashoro-John OA, Bisiriyu LA, Abiodun OO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:153-158

Published Date: 10 May 2014

Effects of body mass index-related disorders on cognition: preliminary results

Yesavage JA, Kinoshita LM, Noda A, Lazzeroni LC, Fairchild JK, Taylor J, Kulick D, Friedman L, Cheng J, Zeitzer JM, O'Hara R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:145-151

Published Date: 8 May 2014

Diabetes and sexual dysfunction: current perspectives

Maiorino MI, Bellastella G, Esposito K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:95-105

Published Date: 6 March 2014

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:1-14

Published Date: 21 December 2013

Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin

Jurczyk A, diIorio P, Brostowin D, Leehy L, Yang C, Urano F, Harlan DM, Shultz LD, Greiner DL, Bortell R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:493-499

Published Date: 13 December 2013

The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects

Lopes AL, Fayh AP, Campos LG, Teixeira BC, Carteri RBK, Ribeiro JL, Friedman R, Reischak-Oliveira A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:469-475

Published Date: 29 November 2013

SGLT-2 inhibitors and their potential in the treatment of diabetes

Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:453-467

Published Date: 27 November 2013

The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review

Rolland C, Mavroeidi A, Johnston KL, Broom J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:393-401

Published Date: 11 October 2013

Socioeconomic status and obesity in Abia State, South East Nigeria

Chukwuonye II, Chuku A, Okpechi IG, Onyeonoro UU, Madukwe OO, Okafor GOC, Ogah OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:371-378

Published Date: 16 October 2013

Radiographic evaluation of the effect of obesity on alveolar bone in rats with ligature-induced periodontal disease

do Nascimento CM, Cassol T, da Silva FS, Bonfleur ML, Nassar CA, Nassar PO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:365-370

Published Date: 7 October 2013

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus

Konya H, Katsuno T, Tsunoda T, Yano Y, Kamitani M, Miuchi M, Hamaguchi T, Miyagawa JI, Namba M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:317-325

Published Date: 2 September 2013

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:293-301

Published Date: 13 August 2013

Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey

Chukwuonye II, Chuku A, Onyeonoro UU, Okpechi IG, Madukwe OO, Umeizudike TI, Ogah OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:285-291

Published Date: 1 August 2013

Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial

Cuevas-Ramos D, Almeda-Valdés P, Chávez-Manzanera E, Meza-Arana CE, Brito-Córdova G, Mehta R, Pérez-Méndez O, Gómez-Pérez FJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:263-273

Published Date: 26 July 2013

Association of FTO and PPARG polymorphisms with obesity in Portuguese women

Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:241-245

Published Date: 11 July 2013

Lorcaserin for weight management

Taylor JR, Dietrich E, Powell J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:209-216

Published Date: 13 June 2013

Management of limited joint mobility in diabetic patients

Abate M, Schiavone C, Salini V, Andia I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:197-207

Published Date: 7 May 2013

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

Ostenson CG, Matthaei S, Reaney M, Krarup T, Guerci B, Kiljanski J, Salaun-Martin C, Sapin H, Bruhn D, Mathieu C, Theodorakis M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:171-185

Published Date: 26 April 2013

Predictors and prevention of diabetic cardiomyopathy

Chavali V, Tyagi SC, Mishra PK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:151-160

Published Date: 11 April 2013

Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

Anichini R, Cosimi S, Di Carlo A, Orsini P, De Bellis A, Seghieri G, Franconi F, Baccetti F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:123-129

Published Date: 8 April 2013

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

Sadosky A, Schaefer C, Mann R, Bergstrom F, Baik R, Parsons B, Nalamachu S, Nieshoff E, Stacey BR, Anschel A, Tuchman M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:79-92

Published Date: 8 February 2013

Prevalence of overweight and obesity in adult Nigerians – a systematic review

Chukwuonye II, Chuku A, John C, Ohagwu KA, Imoh ME, Isa SE, Ogah OS, Oviasu E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:43-47

Published Date: 22 January 2013

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico

García-Alcalá H, Genestier-Tamborero CN, Hirales-Tamez O, Salinas-Palma J, Soto-Vega E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:403-406

Published Date: 19 November 2012

Obstructive sleep apnea and bone mineral density in obese patients

Mariani S, Fiore D, Varone L, Basciani S, Persichetti A, Watanabe M, Saponara M, Spera G, Moretti C, Gnessi L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:395-401

Published Date: 7 November 2012

Association of ADIPOQ +45T>G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population

Guzman-Ornelas MO, Chavarria-Avila E, Munoz-Valle JF, Armas-Ramos LE, Castro-Albarran J, Aguilar Aldrete ME, Oregon-Romero E, Vazquez-Del Mercado M, Navarro-Hernandez RE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:369-378

Published Date: 17 October 2012

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults

Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:347-355

Published Date: 4 October 2012

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa

Latiri I, Elbey R, Hcini K, Zaoui A, Charfeddine B, Maarouf MR, Tabka Z, Zbidi A, Ben Saad H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:227-245

Published Date: 7 August 2012

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:213-217

Published Date: 17 July 2012

Right Diet: a television series to combat obesity among adolescents in Kuwait

Al-Haifi AR, Al-Fayez MA, Al-Nashi B, Al-Athari BI, Bawadi H, Musaiger AO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:205-212

Published Date: 6 July 2012

Obesity: considerations about etiology, metabolism, and the use of experimental models

Pereira-Lancha LO, Campos-Ferraz PL, Lancha Junior AH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:75-87

Published Date: 10 April 2012

Negative association of acetate with visceral adipose tissue and insulin levels

Layden BT, Yalamanchi SK, Wolever TMS, Dunaif A, Lowe Jr WL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:49-55

Published Date: 28 February 2012

Arab Teens Lifestyle Study (ATLS): objectives, design, methodology and implications

Al-Hazzaa HM, Musaiger AO; ATLS Research Group

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:417-426

Published Date: 20 December 2011

Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy

Taylor-Stokes G, Pike J, Sadosky A, Chandran A, Toelle T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:401-408

Published Date: 5 December 2011

Resistance training associated with the administration of anabolic-androgenic steroids improves insulin sensitivity in ovariectomized rats

Urtado CB, Pereira GB, Urtado MB, Carvalho EB, Leite GS, Donatto FF, Assumpção CO, Leite RD, Silva CA, Sales MM, Tibana RA, Alves SCC, Prestes J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:385-391

Published Date: 22 November 2011

Glycemic control and anti-osteopathic effect of propolis in diabetic rats

Al-Hariri M, Gamal Eldin T, Abu-Hozaifa B, Elnour A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:377-384

Published Date: 22 November 2011

Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer

Yekta Z, Pourali R, Nezhadrahim R, Ravanyar L, Ghasemi-rad M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:371-375

Published Date: 13 October 2011

Morning cortisol is lower in obese individuals with normal glucose tolerance

Praveen EP, Sahoo JP, Kulshreshtha B, Khurana ML, Gupta N, Dwivedi SN, Kumar G, Ammini AC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:347-352

Published Date: 7 September 2011

Corrigendum

Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:325-326

Published Date: 17 August 2011

Effect of weight loss on adipokine levels in obese patients

Rolland C, Hession M, Broom I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:315-323

Published Date: 3 August 2011

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring

Abe S, Inoue G, Yamada S, Irie J, Nojima H, Tsuyusaki K, Usui K, Atsuda K, Yamanouchi T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:283-288

Published Date: 13 July 2011

Is obesity in women protective against osteoporosis?

Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:273-282

Published Date: 4 July 2011

Perception of weight and psychological variables in a sample of Spanish adolescents

Jáuregui-Lobera I, Bolaños-Ríos P, Santiago-Fernández MJ, Garrido-Casals O, Sánchez E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:245-251

Published Date: 24 June 2011

Central adiposity and the propensity for rehearsal in children

Ling FCM, Masters RSW, Yu CCW, McManus AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:225-228

Published Date: 17 June 2011

Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton

Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:213-223

Published Date: 16 June 2011

Is vitamin D status a determining factor for metabolic syndrome? A case-control study

Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:205-212

Published Date: 10 June 2011

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease

Bhathena J, Kulamarva A, Martoni C, Urbanska A, Malhotra M,  Paul A, Prakash S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:195-203

Published Date: 3 June 2011

Cardiometabolic results from an armband-based weight loss trial

Sieverdes JC, Sui X, Hand GA, Barry VW, Wilcox S, Meriwether RA, Hardin JW, McClain AC, Blair SN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:187-194

Published Date: 30 May 2011

New onset diabetes after transplantation (NODAT): an overview

Pham PT, Pham PM, Pham SV, Pham PA, Pham PC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:175-186

Published Date: 9 May 2011

Treating statin-intolerant patients

Arca M, Pigna G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:155-166

Published Date: 28 April 2011

Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes

Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:127-135

Published Date: 11 April 2011

Relationship between sleep duration and clustering of metabolic syndrome diagnostic components

Katano S, Nakamura Y, Nakamura A, Murakami Y, Tanaka T, Takebayashi T, Okayama A, Miura K, Okamura T, Ueshima H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:119-125

Published Date: 4 April 2011

Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico

Cuevas-Ramos D, Mehta R, De La Luz-Castro J, Garcia-Rubi E, Aguilar-Salinas CA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:107-117

Published Date: 28 March 2011

Strategy to combat obesity and to promote physical activity in Arab countries

Abdulrahman O Musaiger, Hazzaa M Al Hazzaa, Aayed Al-Qahtani, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:89-97

Published Date: 8 March 2011

Exenatide improves glucocorticoid-induced glucose intolerance in mice

Ruiying Zhao, Enrique Fuentes-Mattei, Guermarie Velazquez-Torres, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:61-65

Published Date: 26 January 2011

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes

Priyanka Gunasekara, Manjula Hettiarachchi, Chandrani Liyanage, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:53-60

Published Date: 26 January 2011

Association of adiponectin levels and insulin demand in critically ill patients

Andreas Hillenbrand, Manfred Weiss, Uwe Knippschild, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:45-51

Published Date: 26 January 2011

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression

Sirada Rungseesantivanon, Naris Thengchaisri, Preecha Ruangvejvorachai, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:421-429

Published Date: 6 December 2010

Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults

Yousef S Khader, Anwar Batieha, Hashim Jaddou, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:395-402

Published Date: 18 November 2010

Lifestyle modification in the management of the metabolic syndrome: achievements and challenges

Riccardo Dalle Grave, Simona Calugi, Elena Centis, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:373-385

Published Date: 2 November 2010

Imaging body composition in obesity and weight loss: challenges and opportunities

Heidi J Silver, E Brian Welch, Malcolm J Avison, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:337-347

Published Date: 28 September 2010

Saxagliptin for type 2 diabetes

Antonio R Chacra, MD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:325-335

Published Date: 22 September 2010

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:311-317

Published Date: 9 September 2010

Beta-cell function is associated with metabolic syndrome in Mexican subjects

Blanca G Baez-Duarte, Maria Del Carmen Sanchez-Guillen, Ricardo Perez-Fuentes, et al.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:301-309

Published Date: 30 August 2010

Optimizing weight control in diabetes: antidiabetic drug selection

S Kalra, B Kalra, AG Unnikrishnan, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:297-299

Published Date: 24 August 2010

The economic impact of obesity in the United States

Ross A Hammond, Ruth Levine

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:285-295

Published Date: 30 August 2010

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes

Sheri R Colberg, Laura C Hill, Henri K Parson, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:275-280

Published Date: 4 August 2010

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes

Joshua J Neumiller, Travis E Sonnett, Lindy D Wood, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:215-226

Published Date: 14 July 2010

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment

B Shariat-Madar, D Kolte, A Verlangieri, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:67-78

Published Date: 19 April 2010

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

Henri K Parson, Meredith A Bundy, Charlotte B Dublin, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:19-26

Published Date: 25 January 2010

A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance

Hidekatsu Yanai, Yoshiharu Tomono, Kumie Ito, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:1-6

Published Date: 18 December 2009

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview

Nanne Kleefstra, Johanna Hortensius, Kornelis JJ van Hateren, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:155-163

Published Date: 9 September 2009

Alogliptin: a new addition to the class of DPP-4 inhibitors

Radha Andukuri, Andjela Drincic, Marc Rendell

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126

Published Date: 21 July 2009

p38 MAPK inhibition reduces diabetes-induced impairment of wound healing

Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, et al.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:91-100

Published Date: 23 June 2009

Management of gestational diabetes mellitus

Annunziata Lapolla, Maria Grazia Dalfrà, Domenico Fedele

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:73-82

Published Date: 17 June 2009

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller, Erin L St Onge, J Roger Accardi

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:23-30

Published Date: 13 May 2009

Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design

Thomas Strack, Luc Martinez, Stefano Del Prato, Larry Blonde, Burkhard Göke, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:1-10

Published Date: 20 January 2009

Comorbidity and glycemia control among patients with type 2 diabetes in primary care

Catherine Hudon, Martin Fortin, Marie-France Dubois, José Almirall

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:33-37

Published Date: 18 November 2008

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes

Bradley Curtis, Risa P Hayes, Sheri Fehnel, Laurie Zografos

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:13-23

Published Date: 14 October 2008

The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes

Juan Churruca, Luis Vigil, Esther Luna, Julian Ruiz-Galiana, Manuel Varela

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:3-11

Published Date: 11 August 2008

Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis

Tsuneyoshi Ka, Yuji Moriwaki, Takeshi Nakanishi, Tetsuya Yamamoto

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:1-2

Published Date: 19 June 2008